Physician profile
Brittany Moses
NPI 1255019386
$714.24
in general payments reported to CMS, 2019-2025
17 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $370 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.25 |
| Education | $173.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $145.60 | 2024-2025 | Enhertu |
| Janssen Biotech, INC. | $104.19 | 2024 | Darzalex, Imbruvica |
| Kestra Medical Technology Services, INC. | $80.11 | 2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $64.97 | 2024-2025 | Verquvo, Reblozyl, Keytruda |
| Abiomed | $57.07 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.09 | 2025 | Lifevest |
| Tactile Systems Technology INC | $36.63 | 2025 | Nimbl, Flexitouch Plus |
| Baxter Healthcare | $36.43 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Karyopharm Therapeutics INC. | $30.44 | 2024 | Xpovio |
| Astellas Pharma US INC | $16.92 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.95 | 2025 | |
| Genentech USA, INC. | $15.48 | 2024 | Tecentriq, Phesgo, Polivy |
| Ipsen Biopharmaceuticals, INC | $15.37 | 2024 | Onivyde, Somatuline Depot |
| Scpharmaceuticals INC. | $14.59 | 2025 | |
| Stemline Therapeutics INC. | $14.39 | 2024 | Orserdu |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.05 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $13.96 | 2024 | Enhertu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Moses listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.